JAK Inhibitors in Myelofibrosis : vimarsana.com

Panel experts briefly review supporting data for the use of JAK inhibitors in myelofibrosis and discuss the impact of emerging data on the current treatment landscape.

Related Keywords

, Myeloproliferative Neoplasms , Jak Inhibitor , Ruxolitinib , Fedratinib , Pacritinib , Momelotinib , Comfort I , Comfort Ii , Jakarta Study , Jakarta 2 , Persist Study , Pacifica Study , Momentum Study , Clinical Trials , Adverse Event Management ,